Global Stem Cells Market Analysis, Drivers, Restraints, Opportunities, Trends, Applications, and Growth Forecast: 2018 to 2029

Global Stem Cells Market Overview:

"The Stem Cells Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031."

Stem cells are special human cells that have the ability to develop into several different types of cell types, from brain cells to muscle cells, and can be used to repair damaged tissue in some cases. Whereas stem cell therapy, also known as regenerative medicine, uses stem cells to prevent or treat a disease or condition.

The success of regenerative medicine and an exponential increase in stem cell-based research are expected to fuel revenue growth of the global stem cell market in the coming years. Due to the high incidence of infections, the demand, awareness, and ongoing R&D for the development of vaccines and the increase in the demand for regenerative medicines are other factors projected to increase the revenue growth of the global stem cells market.

In product market segmentation, the adult stem cells segment is expected to account for the highest revenue share of the market due to the low-risk factors associated with human body compatibility, sub-culturing, and the minimal need for production labor. The iPS segment is projected to register the fastest growth rate over the next 10 years due to its potential to progress clinical research and develop advanced drugs. Implementing IPS cells to explore the genetic link between patients and diseases for new drug discoveries is projected to positively influence this segment's revenue growth.

Regarding application, the regenerative medicine segment accounted for the largest market revenue share in 2019 due to the ongoing development and the increasing adoption of personalized medicine and companion diagnostics for oncological treatments and other chronic diseases.

In 2019, neurology was the highest revenue-producing regenerative medicine segment due to the significant presence of FDA-approved products. The applicability of regenerative medicine in treating Alzheimer’s and Parkinson’s, among other neurodegenerative disorders, is projected to fuel this segment’s revenue growth. The drug discovery & development segment is expected to register the fastest CAGR over the years due to the ease of providing an accurate and less expensive drug testing process.

Concerning technology, the cell acquisition technology segment accounted for the largest revenue share in 2019 and is expected to continue to do so in the foreseeable future. Bone marrow harvest is a common example of an implemented methodology used to acquire stem cells. The cell production segment is expected to grow substantially due to the introduction of novel kits and reagents to optimize the production of stem cells.

Regarding therapy, the allogeneic therapy segment accounted for the largest revenue share in 2019 and is expected to continue to do so over the foreseeable future. The autologous therapy segment is projected to grow expeditiously due to the low-risk complications associated with this form of treatment.

Regional Analysis:

The market in North America accounted for the largest revenue share of the global stem cells market in 2019, owing to high R&D investments in cytological research. Other factors contributing to this are extensive government funding and major biotechnological companies in this region. The Asia Pacific market is projected to grow exponentially owing to a large patient population and strong cell-based therapy product pipelines.

Global Market Segmentation:

By Product:

• Adult Stem Cells (ASCs)
  • Neuronal ASCs
  • Hematopoietic ASCs
  • Mesenchymal ASCs
  • Umbilical Cord ASCs
  • Dental ASCs
  • Adipose‐derived ASCs
  • Dedifferentiated fat (DFAT) Cells
  • Other ASCs
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells
• Very Small Embryonic Like Stem Cells 

By Application:

• Regenerative Medicine
  • Neurology
  • Orthopaedics
  • Oncology
  • Haematology
  • Cardiovascular and Myocardial Infraction
  • Injuries
  • Diabetes
  • Liver Disorder
  • Incontinence
  • Others
• Drug Discovery and Development 

By Technology:

• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion and Sub-Culture 

By Therapy:

• Autologous
• Allogenic 

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa